Sign inSubscribe

target directory

anemia in hemodialysis participants clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.

Validated reports

1

Directory type

target

Association rule

normalized field

NCT03799627
Source recordAI-normalized

Phase 2, Randomized, Open-Label, Active-Controlled, Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of Oral Vadadustat for the Treatment of Anemia in Hemodialysis Subjects Converting From Epoetin Alfa (FO2RWARD-2)

The clinical trial evaluated Vadadustat, an oral medication, for treating anemia in hemodialysis patients transitioning from Epoetin Alfa. Conducted by Akebia Therapeutics, the study aimed to determine the drug's efficacy, safety, and pharmacokinetics in maintaining hemoglobin levels within a target range.

AI analysis

Indication: Anemia

Modality: small molecule

Target: Anemia in Hemodialysis Participants

Sponsor: Akebia Therapeutics

Source URL: ClinicalTrials.gov

Source updated: Sep 29, 2022

Ingested: Jun 03, 2026

Model: trialsignal-ai-v1

Validation: validated

Matched by target_normalized: Anemia in Hemodialysis Participants

View original source fields

Condition raw: Anemia

Condition normalized: Anemia

Modality raw: Anemia

Modality normalized: small molecule

Target raw: Anemia in Hemodialysis Participants

Target normalized: Anemia in Hemodialysis Participants

Open report